271 related articles for article (PubMed ID: 29544742)
1. Increased topical generic prices by manufacturers.
Bhatt MD; Bhatt BD; Dorrian JT; McLellan BN
J Am Acad Dermatol; 2019 May; 80(5):1353-1357. PubMed ID: 29544742
[TBL] [Abstract][Full Text] [Related]
2. Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.
Li DG; Joyce C; Mostaghimi A
JAMA Dermatol; 2018 Dec; 154(12):1441-1446. PubMed ID: 30383117
[TBL] [Abstract][Full Text] [Related]
3. Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015.
Rosenberg ME; Rosenberg SP
JAMA Dermatol; 2016 Feb; 152(2):158-63. PubMed ID: 26606197
[TBL] [Abstract][Full Text] [Related]
4. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R
Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194
[TBL] [Abstract][Full Text] [Related]
5. Do generics offer significant savings to the UK National Health Service?
Kanavos P
Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
[TBL] [Abstract][Full Text] [Related]
6. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
Mansfield SJ
Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Market Competition on the Price of Topical Eye Drops.
Watane A; Kalavar M; Reyes J; Yannuzzi NA; Sridhar J
Semin Ophthalmol; 2022 Jan; 37(1):42-48. PubMed ID: 33780301
[TBL] [Abstract][Full Text] [Related]
8. Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
Yang EJ; Galan E; Thombley R; Lin A; Seo J; Tseng CW; Resneck JS; Bach PB; Dudley RA
JAMA Netw Open; 2020 Dec; 3(12):e2028510. PubMed ID: 33295971
[TBL] [Abstract][Full Text] [Related]
9. Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States.
Alghanem N; Abokwidir M; Fleischer AB; Feldman SR; Alghanem W
J Dermatolog Treat; 2017 Mar; 28(2):119-128. PubMed ID: 27241622
[TBL] [Abstract][Full Text] [Related]
10. The rise of the generic drug market and its implications for dermatology.
Bhosle M; Balkrishnan R; Dewan T; Yelverton CB; Feldman SR
J Dermatolog Treat; 2005; 16(5-6):295-8. PubMed ID: 16428148
[TBL] [Abstract][Full Text] [Related]
11. Medical therapy cost considerations for glaucoma.
Fiscella RG; Green A; Patuszynski DH; Wilensky J
Am J Ophthalmol; 2003 Jul; 136(1):18-25. PubMed ID: 12834665
[TBL] [Abstract][Full Text] [Related]
12. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
13. Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.
Wouters OJ; Kanavos PG; McKEE M
Milbank Q; 2017 Sep; 95(3):554-601. PubMed ID: 28895227
[TBL] [Abstract][Full Text] [Related]
14. Trends in Pricing and Generic Competition Within the Oral Antibiotic Drug Market in the United States.
Alpern JD; Zhang L; Stauffer WM; Kesselheim AS
Clin Infect Dis; 2017 Nov; 65(11):1848-1852. PubMed ID: 29020146
[TBL] [Abstract][Full Text] [Related]
15. A comparison of generic drug prices in seven European countries: a methodological analysis.
Wouters OJ; Kanavos PG
BMC Health Serv Res; 2017 Mar; 17(1):242. PubMed ID: 28359273
[TBL] [Abstract][Full Text] [Related]
16. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
Gross DJ; Schondelmeyer SW; Raetzman SO
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
[TBL] [Abstract][Full Text] [Related]
17. Long-term Medicaid excess payments from alleged price manipulation of generic lorazepam.
Bian B; Gorevski E; Kelton CM; Guo JJ; Martin Boone JE
J Manag Care Pharm; 2012 Sep; 18(7):506-15. PubMed ID: 22971204
[TBL] [Abstract][Full Text] [Related]
18. Pseudo-Generics in South Africa: A Price Comparison.
Bangalee V; Suleman F
Value Health Reg Issues; 2019 Sep; 19():87-91. PubMed ID: 31357098
[TBL] [Abstract][Full Text] [Related]
19. Trends in price for topical corticosteroids from 2017 to 2021 and the opportunity for cost savings identifiable at the point of care: A retrospective cross-sectional study.
Kwa M; Guttentag A; Chase L; van Meijgaard J; Lim HW
J Am Acad Dermatol; 2024 Jan; 90(1):74-81. PubMed ID: 37730020
[TBL] [Abstract][Full Text] [Related]
20. Variation in the Cost of Generic Topical Corticosteroids.
Skojec A; Foulke G; Kirby JS
JAMA Dermatol; 2015 Nov; 151(11):1255-6. PubMed ID: 26288382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
